Signal #160722 · SEC 8-K

$IMCR SEC Filing Alert & Real-Time AI Stock Impact Analysis

Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).

FAQ: $IMCR filing catalyst

Why did $IMCR trigger an AI stock catalyst alert?

$IMCR triggered a Stock Catalyst AI alert on 2026-11-06 14:00:53 UTC for a SEC 8-K filing (AI Score: -2.5/10). Headline: Immunocore Reports Q3 KIMMTRAK Revenue of $102.2M, Net Loss Widens to $14.2M. Key points: - Q3 KIMMTRAK net product revenue declined to $102.2M vs. $103.7M in Q3 2025 (normalized underlying growth ~10%). - Net loss widened to $14.2M ($0.28 per share) compared to $0.2M ($0.00 per share) in prior-year quarter. - Phase 3 TEBE-AM trial completed target enrollment with topline overall survival data expected in Q2 2027.

How did $IMCR stock react after the SEC filing?

After the SEC 8-K for $IMCR, observed market reaction: T0 price $28.40; 4h move +5.63%. Past moves do not guarantee future results.

Where can I get real-time $IMCR SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $IMCR via Telegram and the VIP Web Terminal from €10/month.

$IMCR

$IMCR – Immunocore Reports Q3 KIMMTRAK Revenue of $102.2M, Net Loss Widens to $14.2M

Immunocore Holdings plc

2026-11-06 14:00:53 UTC · SEC 8-K · All $IMCR

Unlocked archive · Analyzed in <2s at T0

Bearish AI Sentiment (-2.5 / 10)

Q3 KIMMTRAK net product revenue declined to $102.2M vs. $103.7M in Q3 2025 (normalized underlying growth ~10%).
Net loss widened to $14.2M ($0.28 per share) compared to $0.2M ($0.00 per share) in prior-year quarter.
Phase 3 TEBE-AM trial completed target enrollment with topline overall survival data expected in Q2 2027.

Observed market reaction after signal

4h +5.63%

Unlock Live VIP Terminal & Telegram – €10/mo Original filing →